226 related articles for article (PubMed ID: 2686418)
1. Comparison of the safety and efficacy of intravenous ciprofloxacin and intravenous ceftazidime in the treatment of selected infections.
Gallis HA; Brennan RO; Goodwin SD; Swinney V; Rumbaugh MM; Drew RH
Am J Med; 1989 Nov; 87(5A):176S-180S. PubMed ID: 2686418
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
Peacock JE; Pegram PS; Weber SF; Leone PA
Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
[TBL] [Abstract][Full Text] [Related]
3. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
Villavicencio J; Asensio de Fernandez ME; Ramirez CA
Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
Quintero-Perez NP; Andrade-Villaneuva JF; Leon-Garnica G; Bertin-Montano M; Rodriguez-Chagollan JJ; Rodriguez-Noriega E
Am J Med; 1989 Nov; 87(5A):198S-201S. PubMed ID: 2686424
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
Levine DP; McNeil P; Lerner SA
Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
[TBL] [Abstract][Full Text] [Related]
6. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections.
Fass RJ; Plouffe JF; Russell JA
Am J Med; 1989 Nov; 87(5A):164S-168S. PubMed ID: 2589361
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections.
Haddow A; Greene S; Heinz G; Wantuck D
Am J Med; 1989 Nov; 87(5A):113S-115S. PubMed ID: 2686410
[TBL] [Abstract][Full Text] [Related]
8. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections.
Gaut PL; Carron WC; Ching WT; Meyer RD
Am J Med; 1989 Nov; 87(5A):169S-175S. PubMed ID: 2686417
[TBL] [Abstract][Full Text] [Related]
9. Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding.
Sifuentes-Osornio J; Macías A; Amieva RI; Ramos A; Ruiz-Palacios GM
Am J Med; 1989 Nov; 87(5A):202S-205S. PubMed ID: 2686425
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous ciprofloxacin in the treatment of selected infections.
Abadie-Kemmerly S; Pankey GA
Am J Med; 1989 Nov; 87(5A):213S-220S. PubMed ID: 2589363
[TBL] [Abstract][Full Text] [Related]
11. Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure.
Gentry LO; Koshdel A
Am J Med; 1989 Nov; 87(5A):132S-135S. PubMed ID: 2686413
[TBL] [Abstract][Full Text] [Related]
12. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
Modai J
Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections.
Trenholme GM; Schmitt BA; Spear J; Gvazdinskas LC; Levin S
Am J Med; 1989 Nov; 87(5A):116S-118S. PubMed ID: 2686411
[TBL] [Abstract][Full Text] [Related]
14. Safety of intravenous ciprofloxacin. A review.
Arcieri GM; Becker N; Esposito B; Griffith E; Heyd A; Neumann C; O'Brien B; Schacht P
Am J Med; 1989 Nov; 87(5A):92S-97S. PubMed ID: 2686431
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
16. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
Khan FA; Basir R
Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
[TBL] [Abstract][Full Text] [Related]
17. Comparative, double-blind study of intravenous ciprofloxacin and intravenous ceftazidime in serious infection.
Ramirez-Ronda CH; Saavedra S; Rivera-Vazquez CR
Am J Med; 1989 Nov; 87(5A):195S-197S. PubMed ID: 2686423
[No Abstract] [Full Text] [Related]
18. Intravenous ciprofloxacin versus ceftazidime for treatment of nosocomial pneumonia and urinary tract infection.
Rapp RP; Billeter M; Hatton J; Young AB; Tibbs PA; Dempsey RJ
Clin Pharm; 1991 Jan; 10(1):49-55. PubMed ID: 1999086
[TBL] [Abstract][Full Text] [Related]
19. Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.
Cox CE
Am J Med; 1989 Nov; 87(5A):157S-159S. PubMed ID: 2686415
[No Abstract] [Full Text] [Related]
20. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
